Deepa Sampath

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 3

Top Topics

Human Immunodeficiency Virus

Artificial Intelligence

Cell Proliferation

Chronic Lymphocytic Leukemia

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Pu Zhang, Lindsey T Brinton, Mehdi Gharghabi, Steven Sher, Katie Williams, Matthew Cannon, Janek S Walker, Daniel Canfield, Larry Beaver, Casey B Cempre, Hannah Phillips, Xuyong Chen, Pearlly S Yan, Amy Lehman, Peggy Scherle, Min Wang, Kris Vaddi, Robert A Baiocchi, Ruoning Wang, Deepa Sampath, Lapo Alinari, James S Blachly, Rosa Lapalombella
Targeting OXPHOS de novo purine synthesis as the nexus of FLT3 inhibitor-mediated synergistic antileukemic actions. Science advances 8 (37) (2022)
Steven Sher, Ethan C Whipp, Janek Walker, Pu Zhang, Larry Beaver, Katie Williams, Shelley J Orwick, Janani Ravikrishnan, Brandi Walker, Elizabeth Perry, Charles T Gregory, Matthew Purcell, Alexander Pan, Pearlly S Yan, Lapo Alinari, Amy J Johnson, Melanie M Frigault, Joy M Greer, Ahmed Hamdy, Raquel Izumi, Xiaokui M Mo, Deepa Sampath, Jennifer A Woyach, James S Blachly, John C Byrd, Rosa Lapalombella
VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia. Leukemia (2022)
Deepa Sampath
Shielding p53 from destruction. Blood 131 (25) (2019)